Alpha Tau Medical's CFO Signals Caution Amidst Soaring Stock and Clinical Hype

Related Articles

Fastly's Insider Exodus: Why CEO Sales Signal Caution Despite AI Hype

3 months ago

What is MY.Alpha Management's Latest Investment Strategy

7 months ago

FMAO's Persistent Insider Selling Signals Caution Ahead of Q2 Earnings

3 months ago

Major Shareholder's $1 Million CACC Stock Sale Signals Caution Ahead of Earnings

3 months ago

Category

You may also like

Stock News•2 months ago

Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough

Alpha Tau approaches a potential inflection point as GBM data is expected before year-end, after two of the first three patients achieved complete responses. Pancreatic data follows shortly, which cou...

DRTS

Share

Stock News•3 months ago

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026

FocalTherics reported preliminary Q2 2026 results for its HIFU segment, after classifying ESWL and Distribution segments as held for sale, a strategic shift that will significantly affect operations a...

FOCL

Share

Stock News•3 months ago

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

QT Imaging received Israeli Ministry of Health registration for its breast scanner, authorizing commercialization in Israel through February 2, 2028, based on existing FDA clearance.

QTI

Share